Last update March 10, 2026

Aspirin (anlgesic, antipyretic, > 300 mg/day)

Likely Compatibility

Fairly safe. Mild or unlikely adverse effects. Compatible under certain circumstances. Follow-up recommended. Read Commentary.

Nonsteroidal anti-inflammatory drug (NSAID) with analgesic, anti-inflammatory, and antipyretic properties. Usually administered orally, every 4-6 hours starting at 500 mg per day to relieve pain or fever.

ANALGESIC-ANTIPYRETIC USE, MEDIUM-HIGH DOSES, > 300 mg/day

Excreted in small amounts in breast milk (Datta 2017, Athavale 2013, Bailey 1982, Findlay 1981, Erickson 1979), but negligible when maternal doses of aspirin are less than 500 mg. (Datta 2017).

Although low plasma levels have been detected in infants (Unsworth 1987), no cases of Reye's syndrome due to aspirin in breast milk have been reported, and it is considered very unlikely to occur with isolated doses. (Shepherd 2020)

Various medical societies, experts, and expert consensus groups consider the occasional isolated use or antiplatelet doses of aspirin during breastfeeding to be safe or probably safe. (Datta 2017, Noviani 2016, Rowe 2013, Sachs 2013, Bell 2011, Chen 2010, Bar -Oz 2003, WHO 2002, Spigset 2000)

With maternal doses in the usual therapeutic analgesic-antipyretic-anti-inflammatory range, there are three older publications on side effects in infants: a highly dubious case of salicylic poisoning in the neonatal period (Clark 1981), thrombocytopenia in an infant (Terragna 1967), and a hemolytic crisis in a 23-day-old newborn with glucose-6-phosphate dehydrogenase deficiency. (Harley 1962)

Other studies have found no problems in infants whose mothers took aspirin. (Ito 1993)

For use in usual doses as an anti-inflammatory, analgesic, or antipyretic, safer alternatives are preferred during breastfeeding. (Noviani 2016, Davanzo 2014, Bloor 2013, Sachs 2013, Worthington 2013, Risser 2009, WHO 2002, Janssen 2000)


See below the information of this related product:

Alternatives

  • Celecoxib (Safe product and/or breastfeeding is the best option.)
  • Diclofenac (Safe product and/or breastfeeding is the best option.)
  • Ibuprofen (Safe product and/or breastfeeding is the best option.)
  • Paracetamol (Safe product and/or breastfeeding is the best option.)
  • Piroxicam (Safe product and/or breastfeeding is the best option.)

Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Other names

Aspirin (anlgesic, antipyretic, > 300 mg/day) is also known as


Aspirin (anlgesic, antipyretic, > 300 mg/day) in other languages or writings:

Group

Aspirin (anlgesic, antipyretic, > 300 mg/day) belongs to this group or family:

Tradenames

Main tradenames from several countries containing Aspirin (anlgesic, antipyretic, > 300 mg/day) in its composition:

  • AAS (Brazil, Spain)
  • ASA
  • ASS
  • Acesal
  • Actron (France)™. Contains other elements than Aspirin (anlgesic, antipyretic, > 300 mg/day) in its composition
  • Actron Compuesto (Spain)™. Contains other elements than Aspirin (anlgesic, antipyretic, > 300 mg/day) in its composition
  • Adolen™. Contains other elements than Aspirin (anlgesic, antipyretic, > 300 mg/day) in its composition
  • Agin™. Contains other elements than Aspirin (anlgesic, antipyretic, > 300 mg/day) in its composition
  • Anacin Advanced Headache™. Contains other elements than Aspirin (anlgesic, antipyretic, > 300 mg/day) in its composition
  • Anacin Max™. Contains other elements than Aspirin (anlgesic, antipyretic, > 300 mg/day) in its composition
  • Aspro
  • Atroveran Composto™. Contains other elements than Aspirin (anlgesic, antipyretic, > 300 mg/day) in its composition
  • Bio-Electro, Bio electro, Bioelectro™. Contains other elements than Aspirin (anlgesic, antipyretic, > 300 mg/day) in its composition
  • Cibalena A™. Contains other elements than Aspirin (anlgesic, antipyretic, > 300 mg/day) in its composition
  • Citramon Maxi Цитрамон Макси™. Contains other elements than Aspirin (anlgesic, antipyretic, > 300 mg/day) in its composition
  • Citramon-F Цитрамон-Ф™. Contains other elements than Aspirin (anlgesic, antipyretic, > 300 mg/day) in its composition
  • Couldina Instant con Ácido Acetilsalicílico™. Contains other elements than Aspirin (anlgesic, antipyretic, > 300 mg/day) in its composition
  • Couldina con Ácido Acetilsalicílico™. Contains other elements than Aspirin (anlgesic, antipyretic, > 300 mg/day) in its composition
  • Desenfriol™. Contains other elements than Aspirin (anlgesic, antipyretic, > 300 mg/day) in its composition
  • Desenfriol C™. Contains other elements than Aspirin (anlgesic, antipyretic, > 300 mg/day) in its composition
  • Disprin
  • Dolider™. Contains other elements than Aspirin (anlgesic, antipyretic, > 300 mg/day) in its composition
  • Doril Enxaqueca™. Contains other elements than Aspirin (anlgesic, antipyretic, > 300 mg/day) in its composition
  • Dristan (India)™. Contains other elements than Aspirin (anlgesic, antipyretic, > 300 mg/day) in its composition
  • Dristan Compuesto™. Contains other elements than Aspirin (anlgesic, antipyretic, > 300 mg/day) in its composition
  • Eau Précieuse™. Contains other elements than Aspirin (anlgesic, antipyretic, > 300 mg/day) in its composition
  • Excedrin™. Contains other elements than Aspirin (anlgesic, antipyretic, > 300 mg/day) in its composition
  • Facitor™. Contains other elements than Aspirin (anlgesic, antipyretic, > 300 mg/day) in its composition
  • Fasconal™. Contains other elements than Aspirin (anlgesic, antipyretic, > 300 mg/day) in its composition
  • Fiorinal (Canada, United States of America)™. Contains other elements than Aspirin (anlgesic, antipyretic, > 300 mg/day) in its composition
  • Goodys Migraine Relief™. Contains other elements than Aspirin (anlgesic, antipyretic, > 300 mg/day) in its composition
  • Matrix Migra™. Contains other elements than Aspirin (anlgesic, antipyretic, > 300 mg/day) in its composition
  • Mejoral (Spain)
  • Melabon K (Germany)™. Contains other elements than Aspirin (anlgesic, antipyretic, > 300 mg/day) in its composition
  • Melabon plus C (Germany)
  • Methoxisal-C (Canada)™. Contains other elements than Aspirin (anlgesic, antipyretic, > 300 mg/day) in its composition
  • Migrainex™. Contains other elements than Aspirin (anlgesic, antipyretic, > 300 mg/day) in its composition
  • Migrane™. Contains other elements than Aspirin (anlgesic, antipyretic, > 300 mg/day) in its composition
  • Okal
  • Resaquit™. Contains other elements than Aspirin (anlgesic, antipyretic, > 300 mg/day) in its composition
  • Robaxisal (Canada, Mexico, Venezuela)™. Contains other elements than Aspirin (anlgesic, antipyretic, > 300 mg/day) in its composition
  • Robaxisal-C (Canada)™. Contains other elements than Aspirin (anlgesic, antipyretic, > 300 mg/day) in its composition
  • Sinutab (Brazil)™. Contains other elements than Aspirin (anlgesic, antipyretic, > 300 mg/day) in its composition
  • Sodol Compound™. Contains other elements than Aspirin (anlgesic, antipyretic, > 300 mg/day) in its composition
  • Splentir™. Contains other elements than Aspirin (anlgesic, antipyretic, > 300 mg/day) in its composition
  • Synalgos-DC™. Contains other elements than Aspirin (anlgesic, antipyretic, > 300 mg/day) in its composition
  • Tabcin (Mexico)™. Contains other elements than Aspirin (anlgesic, antipyretic, > 300 mg/day) in its composition
  • Tafirol Migra™. Contains other elements than Aspirin (anlgesic, antipyretic, > 300 mg/day) in its composition
  • Tetralgin APC™. Contains other elements than Aspirin (anlgesic, antipyretic, > 300 mg/day) in its composition
  • Vasclin™. Contains other elements than Aspirin (anlgesic, antipyretic, > 300 mg/day) in its composition
  • Veganin™. Contains other elements than Aspirin (anlgesic, antipyretic, > 300 mg/day) in its composition

Pharmacokinetics

Variable Value Unit
Oral Bioavail. 40 - 75 %
Molecular weight 180 daltons
Protein Binding 70 - 95 %
VD 0.15 l/Kg
Tmax 1 - 2 hours
7 (3 - 10) hours
M/P ratio 0.03 - 0.34 -
Relative Dose 2.5 - 23.3 %

References

  1. Shepherd E, Grivell RM. Aspirin (single dose) for perineal pain in the early postpartum period. Cochrane Database Syst Rev. 2020 Jul 24;7(7):CD012129. Abstract Full text (link to original source)
  2. Datta P, Rewers-Felkins K, Kallem RR, Baker T, Hale TW. Transfer of Low Dose Aspirin Into Human Milk. J Hum Lact. 2017 May;33(2):296-299. Abstract
  3. Noviani M, Wasserman S, Clowse ME. Breastfeeding in mothers with systemic lupus erythematosus. Lupus. 2016 Aug;25(9):973-9. Abstract
  4. Davanzo R, Bua J, Paloni G, Facchina G. Breastfeeding and migraine drugs. Eur J Clin Pharmacol. 2014 Abstract
  5. Bloor M, Paech M. Nonsteroidal anti-inflammatory drugs during pregnancy and the initiation of lactation. Anesth Analg. 2013 Abstract
  6. Worthington I, Pringsheim T, Gawel MJ, Gladstone J, Cooper P, Dilli E, Aube M, Leroux E, Becker WJ; Canadian Headache Society Acute Migraine Treatment Guideline Development Group. Canadian Headache Society Guideline: acute drug therapy for migraine headache. Can J Neurol Sci. 2013 Sep;40(5 Suppl 3):S1-S80. Review. Abstract Full text (in our servers)
  7. Sachs HC; Committee On Drugs. The transfer of drugs and therapeutics into human breast milk: an update on selected topics. Pediatrics. 2013 Sep;132(3):e796-809. Abstract Full text (link to original source) Full text (in our servers)
  8. Rowe H, Baker T, Hale TW. Maternal medication, drug use, and breastfeeding. Pediatr Clin North Am. 2013 Feb;60(1):275-94. Abstract
  9. Athavale MA, Maitra A, Patel S, Bhate VR, Toddywalla VS. Development of an in vitro cell culture model to study milk to plasma ratios of therapeutic drugs. Indian J Pharmacol. 2013 Abstract Full text (link to original source) Full text (in our servers)
  10. Bell AD, Roussin A, Cartier R, Chan WS, Douketis JD, Gupta A, Kraw ME, Lindsay TF, Love MP, Pannu N, Rabasa-Lhoret R, Shuaib A, Teal P, Théroux P, Turpie AG, Welsh RC, Tanguay JF. The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society Guidelines Executive Summary. Can J Cardiol. 2011 Abstract
  11. Chen LH, Zeind C, Mackell S, LaPointe T, Mutsch M, Wilson ME. Breastfeeding travelers: precautions and recommendations. J Travel Med. 2010 Jan-Feb;17(1):32-47. Abstract Full text (in our servers)
  12. Risser A, Donovan D, Heintzman J, Page T. NSAID prescribing precautions. Am Fam Physician. 2009 Abstract Full text (link to original source) Full text (in our servers)
  13. Bar-Oz B, Bulkowstein M, Benyamini L, Greenberg R, Soriano I, Zimmerman D, Bortnik O, Berkovitch M. Use of antibiotic and analgesic drugs during lactation. Drug Saf. 2003 Abstract
  14. WHO / UNICEF. BREASTFEEDING AND MATERNAL MEDICATION Recommendations for Drugs in the Eleventh WHO Model List of Essential Drugs. Department of Child and Adolescent Health and Development (WHO/UNICEF) 2002 Abstract Full text (link to original source) Full text (in our servers)
  15. Janssen NM, Genta MS. The effects of immunosuppressive and anti-inflammatory medications on fertility, pregnancy, and lactation. Arch Intern Med. 2000 Abstract Full text (link to original source) Full text (in our servers)
  16. Spigset O, Hägg S. Analgesics and breast-feeding: safety considerations. Paediatr Drugs. 2000 Abstract
  17. Ito S, Blajchman A, Stephenson M, Eliopoulos C, Koren G. Prospective follow-up of adverse reactions in breast-fed infants exposed to maternal medication. Am J Obstet Gynecol. 1993 May;168(5):1393-9. Abstract
  18. McGeorge BC, Steele MC. Allergic contact dermatitis of the nipple from Roman chamomile ointment. Contact Dermatitis. 1991 Feb;24(2):139-40. No abstract available. Abstract
  19. Unsworth J, d'Assis-Fonseca A, Beswick DT, Blake DR. Serum salicylate levels in a breast fed infant. Ann Rheum Dis. 1987 Aug;46(8):638-9. Abstract Full text (link to original source)
  20. Bailey DN, Weibert RT, Naylor AJ, Shaw RF. A study of salicylate and caffeine excretion in the breast milk of two nursing mothers. J Anal Toxicol. 1982 Abstract
  21. Findlay JW, DeAngelis RL, Kearney MF, Welch RM, Findlay JM. Analgesic drugs in breast milk and plasma. Clin Pharmacol Ther. 1981 May;29(5):625-33. Abstract
  22. Clark JH, Wilson WG. A 16-day-old breast-fed infant with metabolic acidosis caused by salicylate. Clin Pediatr (Phila). 1981 Abstract
  23. Erickson SH, Oppenheim GL. Aspirin in breast milk. J Fam Pract. 1979 Abstract
  24. Terragna A, Spirito L. [Thrombocytopenic purpura in an infant after administration of acetylsalicylic acid to the wet-nurse] (Cited in: Aspirin. Toxnet-LactMed, access 10.06.2018) Minerva Pediatr. 1967 Abstract
  25. Harley JD, Robin H. "Late" neonatal jaundice in infants with glucose-6-phosphate dehydrogenase-deficient erythrocytes (Cited in: Aspirin. Toxnet-LactMed, access 10.06.2018). Australas Ann Med. 1962 Abstract

Total visits

890,129

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at elactancia.org@gmail.com

e-lactancia is a resource recommended by AELAMA of Spain

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM